Showing 35,861 - 35,880 results of 38,494 for search 'Flowey~', query time: 2.27s Refine Results
  1. 35861
  2. 35862

    Pengembangan Animasi Keterampilan Berbicara Bahasa Inggris dengan Multimedia Development Life Cycle Godfrey by Nisa'ul Hafidhoh, Liya Umaroh, Sugiyanto Sugiyanto

    Published 2020-02-01
    “…Survey shows that English speaking skills in the community are lower than reading and listening skills. Speaking skills can be trained through audio aspects to hear English sentences and visual aspects to see English sentences. …”
    Get full text
    Article
  3. 35863

    Health-Related Quality of Life and Psychological Outcomes in Participants with Symptomatic and Non-Symptomatic Knees after ACL Reconstruction by Johanna M. Hoch, Ansley Swann, Rachel Kleis, Matthew C. Hoch, Carrie Baker, Dee Dlugonski

    Published 2024-02-01
    “…The authors’ hypothesized participants classified as symptomatic would have lower HRQL, increased fear-avoidance beliefs, and decreased resilience compared to participants classified as non-symptomatic…”
    Get full text
    Article
  4. 35864

    Predictors of long-term symptom burden and quality of life in patients hospitalised with chest pain: a prospective observational study by Tone Merete Norekvål, Jørund Langørgen, Torbjørn Omland, Øyvind Skadberg, Kjell Vikenes, Nasir Saeed, Ole-Thomas Steiro, Hilde Lunde Tjora, Rune Oskar Bjørneklett, Vernon Vijay Singha Bonarjee, Øistein Rønneberg Mjelva, Kristin Moberg Aakre

    Published 2022-07-01
    “…Patients with other diseases, in particular UAP patients, reported lower scores. Revascularised NSTEMI and UAP patients reported higher QoL scores compared with patients receiving conservative treatment. …”
    Get full text
    Article
  5. 35865

    Characteristics and outcomes of out-of-hospital cardiac arrest among students under school supervision in Japan: a descriptive epidemiological study (2008–2021) by Kosuke Kiyohara, Mamoru Ayusawa, Masahiko Nitta, Takeichiro Sudo, Taku Iwami, Ken Nakata, Yuri Kitamura, Tetsuhisa Kitamura

    Published 2025-01-01
    “…One-month survival with favorable neurological outcomes was significantly lower in non-cardiac (6.6%) and traumatic cases (0%) than that in cardiac cases (50.2%; p < 0.001). …”
    Get full text
    Article
  6. 35866

    The vestibular and oculomotor dysfunction in Fabry disease: a cohort study in China by Yinglin Leng, Yawen Zhao, Hong Zhou, Xia Ling, Xia Wang, Guiping Zhao, Wei Zhang

    Published 2025-12-01
    “…Statistical tests showed: (1) significantly higher Mainz Severity Score Index in patients with prolonged saccade latency [20(18,33) VS 13(9,22), p = 0.008] and vestibulo-oculomotor dysfunction [23(20,31) VS 9(5.5,12.5), p = 0.024], (2) significantly higher total small-vessel disease score in subgroups with prolonged saccade latency [2.5(1,3.5) VS 1(0,2), p = 0.038], defective smooth pursuit [3(2,4) VS 1(0,2), p = 0.003], defective optokinetic nystagmus [4(2,4) VS 1(0.2), p = 0.009] and vestibulo-oculomotor dysfunction [1(1,3) VS 0(0,1), p = 0.028], (3) significantly lower α-Gal A activity (μmol/L/h) in subgroups with defective saccades [0.44(0.25,1.93) VS 1.85(0.75,5.52), p = 0.015] and defective smooth pursuit [0.30(0.17,0.44) VS 0.96(0.39,2.40), p = 0.008], and (4) significantly elevated plasma globotriaosylsphingosine (ng/ml) in patients with defective saccades [74.16(11.05,89.18) VS 10.64(7.08,36.32), p = 0.034], than in patients without those abnormalities.Conclusion A high incidence of extensive vestibular and oculomotor dysfunction was observed in patients with FD, with the neuro-otological dysfunction being closely related to the disease burden and biomarkers like α-Gal A activity and lyso-Gb3.…”
    Get full text
    Article
  7. 35867

    Prevention of sufentanil-induced cough during induction of general anesthesia by low-dose esketamine by Xueyue Zhou, Chaoping Guo, Boyu Liu, Yongqing Guan, Shengxiang Wang, Jun Ji

    Published 2025-01-01
    “…The incidence of cough in Group E (6.0%) was significantly lower than that in Group C (34.7%) (P < 0.001), and the severity of cough was also significantly milder than that in Group C (P = 0.038). …”
    Get full text
    Article
  8. 35868

    The relationships of metals exposure and disturbance of the vaginal microbiota with the risk of PROM: Results from a birth cohort study by Dongyang Zhang, Rui Dong, Tingting Jiang, Shiwei Ren, Xinyu Yue, Muxin Zhai, Siyu Jiang, Bingxia He, Ran Tang, Yujie Deng, Wenjie Lyu, Baojing Zhao, Fangbiao Tao, Yuanyuan Yang, Zongzhi Yin, Zhen Yu, Dongmei Ji, Chunmei Liang

    Published 2025-01-01
    “…Further verification analysis exploring the potential cause of the above phenomenon indicated that the neutrophil count, one of blood inflammation indicators for PROM, was higher in women with the absence of Collinsella (p value = 0.039), moreover, the cumulative hazard of PROM for women with the presence of Collinsella was also significantly lower than that of those without Collinsella (p value = 0.007). …”
    Get full text
    Article
  9. 35869

    Predictors of food security status among informal caregivers of older adults residing in slums in Ghana by Dina Adei, Williams Agyemang-Duah, Bright Osei Boateng, Anthony Acquah Mensah

    Published 2025-02-01
    “…Beta values and standard errors were utilised, with a significance level of 0.05 or lower. Results The analysis showed that 88.4% of the participants were females, 37.3% were aged 40–49 years, 72.7% were of Akan ethnicity, 81.4% were married, 45.4% had basic education, 96.3% did not receive pay for caregiving and 72.1% were enrolled in a national health insurance scheme. …”
    Get full text
    Article
  10. 35870

    Retrospective Analysis of RSV Infection in Pediatric Patients: Epidemiology, Comorbidities, Treatment, and Costs in Dubai (2014-2023) by Jean Joury, Nawal Al Kaabi, Sara Al Dallal, Bassam Mahboub, Mostafa Zayed, Mohamed Abdelaziz, Jennifer Onwumeh-Okwundu, Mark A. Fletcher, Subramanyam Kumaresan, Badarinath C. Ramachandrachar, Mohamed Farghaly

    Published 2024-11-01
    “…In Cohort 1, 32.0% had upper respiratory tract infections, 39.4% had lower respiratory tract infections, and 44.4% of patients had an “other respiratory disease.” …”
    Get full text
    Article
  11. 35871

    Blood Lipid Levels and Their Value as Markers of Disease Activity in Severe Ulcerative Colitis by Zhu L, Tian L, Li S, Huo L

    Published 2025-02-01
    “…We divided the patients with UC into non-severe and severe groups, analyzed the relationship between blood lipid levels and severe UC, and evaluated the early predictive value of blood lipid indicators for severe UC.Results: Compared with healthy individuals, patients with UC had lower total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and non-HDL-C levels (P< 0.05). …”
    Get full text
    Article
  12. 35872

    Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case–control study by Wei Li, Aoying Min, Wei Zhao, Weining Li, Shuhan Li, Saidi Ran, Mingming Fu, Qili Yu, Junkai Kou, Zhiqian Wang, Zhiyong Hou

    Published 2025-01-01
    “…Kaplan–Meier survival curves revealed a significantly lower overall survival rate in elderly hip fracture patients with AF, especially permanent AF. …”
    Get full text
    Article
  13. 35873

    Palliative care needs and quality of life among adults with advanced chronic illnesses in low-income communities of Bangladesh by Ahmed Hossain, Maruf Hasan, Taifur Rahman, Alounoud Almarzooqi, Syed Azizur Rahman, Heba Hijazi, Mohamad Alameddine

    Published 2025-01-01
    “…Female patients had poorer QOL than males across all domains, and those facing financial hardships also experienced significantly lower QOL. Conclusion In Bangladesh’s low-income communities, a significant proportion of patients with chronic illnesses require palliative care (PC) due to advanced conditions. …”
    Get full text
    Article
  14. 35874

    Role of Chest X-Ray in Coronavirus Disease and Correlation of Radiological Features with Clinical Outcomes in Indian Patients by Satyanand Sathi, Richa Tiwari, Savita Verma, Anil Kumar Garg, Virendra Singh Saini, Manoj Kumar Singh, Amit Mittal, Devinder Vohra

    Published 2021-01-01
    “…Among 120 COVID-19 patients, 74 (61.67%) and 46 (38.33%) were males and females, respectively; 64 patients (53.33%) had ground-glass opacities (GGO), 55 (45.83%) had consolidation, and 38 (31.67%) had reticular-nodular opacities, with lower zone distribution (50%) and peripheral distribution (41.67%). …”
    Get full text
    Article
  15. 35875

    Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial by Lauren Powell, Fiona O’Sullivan, Pramoda Jayasinghe, Basia Rogula, Feng Dai, Jessica Cirillo, Samantha Sweeney, Lucy Abraham, Jessica Ailani

    Published 2025-01-01
    “…In a regression model, treatment with zavegepant, lower pain severity, fewer baseline monthly migraine days, and absence of photophobia, phonophobia, and nausea were associated with better functioning (p < 0.05) over 48-h. …”
    Get full text
    Article
  16. 35876

    Effect of Third-Generation Beta Blockers on Weight Loss in a Population of Overweight-Obese Subjects in a Controlled Dietary Regimen by Maria Alessandra Gammone, Konstantinos Efthymakis, Nicolantonio D’Orazio

    Published 2021-01-01
    “…After 6 months, the percent total weight loss (TWL%) was lower in the bB group (3.62 ± 1.96 versus 5.27 ± 1.76 in the bB-3 group, versus 5.15 ± 1.30 in the non-bB group, and versus 4.70 ± 0.87 in the control group), as well as their BMI. …”
    Get full text
    Article
  17. 35877

    Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study by Paola Pantanetti, Giovanni Cangelosi, Sara Morales Palomares, Gaetano Ferrara, Federico Biondini, Stefano Mancin, Gabriele Caggianelli, Mauro Parozzi, Marco Sguanci, Fabio Petrelli

    Published 2025-01-01
    “…Conclusions: The transition to the Medtronic Smart MDI system significantly enhanced glycemic control by lowering mean glucose levels and increasing TIR. These findings highlight its efficacy in improving hyperglycemia management while maintaining a stable risk of hypoglycemia.…”
    Get full text
    Article
  18. 35878

    5-year migration and inducible displacement of the uncemented LCS and ATTUNE rotating platform knee systems: a secondary report of a randomized controlled RSA trial by Raymond Puijk, Lennard A Koster, Bart G C W Pijls, Jiwanjot Singh, Marjolein Schager, Bart L Kaptein, Peter A Nolte

    Published 2025-01-01
    “…The mean MTPM was similar for tibial components (ATTUNE 1.13mm [confidence interval (CI) 0.94–1.33]; LCS 1.24 mm [CI 1.05–1.46]) but significantly lower for the ATTUNE femoral component (1.14 mm [CI 0.92–1.39]) than LCS 1.87 mm [CI 1.57–2.21]). 2-to-5-year migration rates were comparable, but 11 ATTUNE and 7 LCS exceeded 0.10 mm MTPM/year, indicating a higher risk of loosening. …”
    Get full text
    Article
  19. 35879

    Effect of Cinnamon Essential Oil on the Chemotherapy-Induced Nausea and Vomiting of Cancer Patients by Shima Mehrabian, Batool Tirgari, Mina Beitollahi, Mansooreh Azizzadeh Forouzi, Behjat Kalantari Khandani

    Published 2025-01-01
    “…The severity of chemotherapy-induced nausea and vomiting was significantly lower in the cinnamon group than the control group after the first 3.08 (0.55), (F2 = 13.27, p < 0.001) and second breaths 1.91 (0.33) (F2 = 11.39, p < 0.001). …”
    Get full text
    Article
  20. 35880

    Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study by Tao Gu, Neel Shah, Gaurav Deshpande, Derek H. Tang, Debra F. Eisenberg, David J. Harrison

    Published 2015-09-01
    “…Average first-year biologic cost per effectively treated patient was significantly lower for etanercept ($50 217) than for golimumab ($56 427, p<0.001) adalimumab ($56 879, p<0.001), abatacept ($68 062, p<0.001), certolizumab pegol ($76 427, p<0.001), and infliximab ($95 126, p<0.001). …”
    Get full text
    Article